Full name
NANTES PLAZMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.79.Z - Retail sale of used products
10.86.Z - Production of homogenized food products and diet food
11.07.Z - Production of non-alcoholic beverages and bottled water
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
72.11.Z - Scientific research and development activities
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 21,9 | 15,2 | 10 | -34,7 |
Gross profit (loss) | -72,8 | 2,5 | 14,7 | 477 |
EBITDA | -72,5 | 4,2 | 18,8 | 350,6 |
Net profit (loss) | -72,8 | 2,5 | 14,7 | 477 |
Cash | 9,2 | 5,9 | 9,2 | 55,3 |
Net income from sale | 359,1 | 12,3 | 26,4 | 115,4 |
Liabilities and provisions for liabilities | 177,9 | 168,7 | 148,8 | -11,8 |
Short time liabilities | 81,9 | 72,7 | 48,6 | -33,1 |
Equity capital | -156 | -153,5 | -138,8 | 9,6 |
Working assets | 21,9 | 15,2 | 10 | -34,7 |
Operating profit (EBIT) | -72,5 | 4,2 | 18,8 | 350,6 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 46,7 | -1,7 | -10,6 | -8,9 |
Equity capital to total assets | -713,7 | -1006,5 | -1394,6 | -388,1 |
Gross profit margin | -20,3 | 20,7 | 55,6 | 34,9 |
EBITDA Margin | -20,2 | 34,1 | 71,3 | 37,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 83 | 2167 | 673 | -1494 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane